Simon Malpas, founder and chief executive of medtech startup Kitea Health, is outraged at what he calls a lack of funding for health-tech in this year’s funding from the Endeavour Fund, the country’s largest contestable research fund.
These grants are designed to be the front end of R&D from
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
